Cardiac ischaemia leads to an inhibition of beta-oxidation flux and an
accumulation of acyl-CoA and acyl-carnitine esters in the myocardium.
However, there remains some uncertainty as to which esters accumulate
during cardiac ischaemia and therefore the site of inhibition of beta
-oxidation [Moore, Radloff, Hull and Sweely (1980) Am. J. Physiol. 239
, H257-H265; Latipaa (1989) J. Mol. Cell. Cardiol. 21, 765-771]. When
beta-oxidation of hexadecanoyl-CoA in state III rat heart mitochondria
was inhibited by titration of complex III activity, flux measured as
(CO2)-C-14 release, acid-soluble radioactivity or as acetyl-carnitine:
was progressively decreased. Low concentrations of myxothiazol caused
reduction of the ubiquinone pool whereas the NAD(+)/NADH redox state
was less responsive. Measurement of the CoA and carnitine esters gener
ated under these conditions showed that there was a progressive decrea
se in the amounts of chain-shortened saturated acyl esters with increa
sing amounts of myxothiazol. The concentrations of 3-hydroxyacyl and 2
-enoyl esters, however, were increased between 0 and 0.2 mu M myxothia
zol but were lowered at higher myxothiazol concentrations. More hexade
canoyl-CoA and hexadecanoyl-carnitine were present with increasing con
centrations of myxothiazol. We conclude that 3-hydroxyacyl-CoA dehydro
genase and acyl-CoA dehydrogenase activities are inhibited by reductio
n of the ubiquinone pool, and that this explains the confusion over wh
ich esters of CoA and carnitine accumulate during cardiac ischaemia. F
urthermore these studies demonstrate that the site of the control exer
ted by the respiratory chain over beta-oxidation is shifted depending
on the extent of the inhibition of the respiratory chain.